Posted on 3 Comments

Skin Cancer Breakthrough: How Moderna’s New Custom mRNA Vaccine Halves Recurrence Risk

295363587 5426511264054341 1903068887437012708 n

Custom-Built mRNA Vaccines: The New Frontier in Skin Cancer Treatment

file photo by Boyd Loving

the staff of the Ridgewood blog

Ridgewood NJ, Scientists are unlocking a massive breakthrough in oncology: turning the body’s immune system into a targeted defense against melanoma, the deadliest form of skin cancer. Pharmaceutical powerhouses Moderna and Merck recently reported groundbreaking results from late-stage trials testing a personalized mRNA vaccine designed to keep skin cancer from returning or spreading.

Continue reading Skin Cancer Breakthrough: How Moderna’s New Custom mRNA Vaccine Halves Recurrence Risk